Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases

(2010) Alexis B. Cortot et al.   CANCER

Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer

(2010) Sarah Park et al.   Journal of Thoracic Oncology

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

(2009) K. Schmid et al.   CLINICAL CANCER RESEARCH

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

(2009) Sara E. Monaco et al.   HUMAN PATHOLOGY

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2009) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

(2008) A Kalikaki et al.   BRITISH JOURNAL OF CANCER

Reversed mutation rates ofKRASandEGFRgenes in adenocarcinoma of the lung in Taiwan and their implications

(2008) Chun-Chieh Wu et al.   CANCER

Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib

(2008) Kazuya Taniguchi et al.   CANCER SCIENCE

Integrating Epidermal Growth Factor Receptor–Targeted Therapies into Platinum-Based Chemotherapy Regimens for Newly Diagnosed Non–Small-Cell Lung Cancer

(2008) Robert Pirker et al.   Clinical Lung Cancer

Targeted Therapies in Lung Cancer

(2008) Robert Pirker et al.   CURRENT PHARMACEUTICAL DESIGN

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites

(2008) Cecilia Bozzetti et al.   Journal of Thoracic Oncology

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology